Correlation Between Ibio and Vaxart
Can any of the company-specific risk be diversified away by investing in both Ibio and Vaxart at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and Vaxart into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and Vaxart Inc, you can compare the effects of market volatilities on Ibio and Vaxart and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of Vaxart. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and Vaxart.
Diversification Opportunities for Ibio and Vaxart
Very good diversification
The 3 months correlation between Ibio and Vaxart is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and Vaxart Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxart Inc and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with Vaxart. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxart Inc has no effect on the direction of Ibio i.e., Ibio and Vaxart go up and down completely randomly.
Pair Corralation between Ibio and Vaxart
Given the investment horizon of 90 days Ibio Inc is expected to generate 2.2 times more return on investment than Vaxart. However, Ibio is 2.2 times more volatile than Vaxart Inc. It trades about 0.02 of its potential returns per unit of risk. Vaxart Inc is currently generating about 0.01 per unit of risk. If you would invest 1,232 in Ibio Inc on August 30, 2024 and sell it today you would lose (969.00) from holding Ibio Inc or give up 78.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ibio Inc vs. Vaxart Inc
Performance |
| Timeline |
| Ibio Inc |
| Vaxart Inc |
Ibio and Vaxart Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ibio and Vaxart
The main advantage of trading using opposite Ibio and Vaxart positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, Vaxart can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will offset losses from the drop in Vaxart's long position.| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |